National Institute of Health

Statens Serum Institut of Denmark (SSI)

Partnership commencement date : 2021. 6. 28.

Responsible team : Division of Infectious Diseases Research Planning

What we do in partnership

• Strengthening mutual cooperation for sharing vaccine production information, including each institution’s roles in vaccine development, vaccine development and progress in research, and Mix and match vaccination issues in order to ensure safe and effective development and supply of COVID-19 vaccines

U.S. National Institute of Allergy and Infectious Diseases (NIAID)

Partnership commencement date : 2021. 5. 18.

Responsible team : Division of Vaccine Clinical Research

What we do in partnership

• Exchanging expression of interest (EOI) letters for research cooperation in vaccines and medications
• Prioritizing research in vaccine development and medications for new infectious diseases, including COVID-19
• Planning to conduct research on vaccines and medications for tuberculosis, antibiotic resistance, and immunology of infectious diseases.

U.S. Moderna

Partnership commencement date : 2021. 5. 22.

Responsible team : Division of Infectious Disease Vaccine Research

What we do in partnership

• mRNA vaccine research cooperation for COVID-19 and infectious diseases of mutual interest

UN International Vaccine Institute (IVI)

Partnership commencement date : 2012. 7. 20.

Responsible team : Division of Vaccine Development Coordination

What we do in partnership

• Creating synergies through mutual cooperation for vaccine research

Leibniz Institute DSMZ

Partnership commencement date : 2011. 11. 28.

Responsible team : Division of Pathogen Resource Management

What we do in partnership

• Building an organic network for the exchange and research of microbial resources, including pathogens